Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Lucy Fletcher and Richard Haynes

Two RECOVERY Trial team members have been recognised in the New Year Honours list 2022, published today.  

RECOVERY Trial coordinator, Professor Richard Haynes, has been appointed Member of the Order of the British Empire (MBE) for services to Global Health, and Senior Clinical Trial Manager, Lucy Fletcher, has been appointed MBE for services to Clinical Trials. 

The New Year Honours list recognises outstanding achievements by a wide range of extraordinary people from across the United Kingdom. People are awarded honours for achievements in their field of work (including health, education, science and technology), as well as for making a difference to their community. 

Professor Richard Haynes said ‘I am excited, flattered and embarrassed to receive this honour. I am only receiving this because of the incredible efforts of my friends and colleagues in the RECOVERY team and wider university. I dedicate it to them, and to all of our collaborators at hospitals in the NHS and around the world who have given themselves to this effort. 

‘COVID-19 has brought out the best in health services staff everywhere and I am very proud to be a small part of that. Above all, I would like to thank all of our participants who so bravely took the decision to participate in such difficult circumstances without whose contribution RECOVERY could not succeed.’ 

Lucy Fletcher added ‘It is a privilege to receive this honour for services to Clinical Trials. My recent involvement in the management of the RECOVERY trial of treatments for COVID-19 has been an extraordinary and hugely rewarding experience. I am delighted to have had the opportunity to contribute to what has been such an important and impactful collaboration. I feel very fortunate to work with many incredibly dedicated and supportive colleagues and although I am extremely flattered to receive this personal recognition, it is undoubtedly a reflection of the efforts of our entire team.’ 

Professor Haynes joined the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), now part of Oxford Population Health, in 2006 to work on large-scale randomised trials in kidney and cardiovascular disease. He is an honorary consultant at the Oxford Kidney Unit, and is also an MRC Investigator, co-leading the randomised trials programme at the Medical Research Council Population Health Research Unit at the University of Oxford. 

Lucy Fletcher also joined CTSU in 2006. She oversaw the team that coordinates trial activities for each of the hospital sites participating in RECOVERY. Lucy’s background is in clinical trial management, specifically trial and data management for large-scale, randomised trials both nationally and internationally. She is particularly interested in developing trial methodology in order to further streamline large-scale clinical trials to improve trial efficiency. 

Richard Haynes and Lucy Fletcher are amongst seven members of the University of Oxford to be honoured this year. Visit the University of Oxford website for the full list of those recognised today.